{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:20:13Z","timestamp":1789885213660,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Key R&D Program of China","award":["2017YFD0501705"],"award-info":[{"award-number":["2017YFD0501705"]}]},{"name":"National Major Infectious Projects of China","award":["2016ZX10004502-005"],"award-info":[{"award-number":["2016ZX10004502-005"]}]},{"name":"National Science and Technology Major Project of China","award":["2014ZX09102044-007"],"award-info":[{"award-number":["2014ZX09102044-007"]}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["U1504823"],"award-info":[{"award-number":["U1504823"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.vaccine.2018.08.053","type":"journal-article","created":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T01:11:08Z","timestamp":1535591468000},"page":"5990-5998","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Inclusion of membrane-anchored LTB or flagellin protein in H5N1 virus-like particles enhances protective responses following intramuscular and oral immunization of mice"],"prefix":"10.1016","volume":"36","author":[{"given":"Zhiguang","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongkun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianliang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingnan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiecheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanguo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hualei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songtao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhizeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianzhu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.08.053_b0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.7774\/cevr.2014.3.2.117","article-title":"Evolutionary dynamics of highly pathogenic avian influenza A\/H5N1 HA clades and vaccine implementation in Vietnam","volume":"3","author":"Le","year":"2014","journal-title":"Clin Exp Vacc Res"},{"key":"10.1016\/j.vaccine.2018.08.053_b0010","doi-asserted-by":"crossref","first-page":"e1002068","DOI":"10.1371\/journal.ppat.1002068","article-title":"Acquisition of human-type receptor binding specificity by new H5N1 influenza virus sublineages during their emergence in birds in Egypt","volume":"7","author":"Watanabe","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2018.08.053_b0015","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.vaccine.2013.01.003","article-title":"Cross-protective efficacy of bivalent recombinant baculoviral vaccine against heterologous influenza H5N1 challenge","volume":"31","author":"Prabakaran","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.053_b0020","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMoa020586","article-title":"A controlled trial of a human papillomavirus type 16 vaccine","volume":"347","author":"Koutsky","year":"2002","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2018.08.053_b0025","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1128\/JVI.01720-06","article-title":"Proteasome-independent major histocompatibility complex class I cross-presentation mediated by papaya mosaic virus-like particles leads to expansion of specific human T cells","volume":"81","author":"Leclerc","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.08.053_b0030","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.antiviral.2007.05.005","article-title":"Humoral and cellular immune responses to airway immunization of mice with human papillomavirus type 16 virus-like particles and mucosal adjuvants","volume":"76","author":"Revaz","year":"2007","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2018.08.053_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2015.01.007","article-title":"H5N1 influenza virus-like particle vaccine protects mice from heterologous virus challenge better than whole inactivated virus","author":"Ren","year":"2015","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2018.08.053_b0040","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1128\/CMR.14.2.430-445.2001","article-title":"Vaccination strategies for mucosal immune responses","volume":"14","author":"Ogra","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2018.08.053_b0045","unstructured":"Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB, Centers for Disease C, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports\/Centers for Disease Control; 2004, vol. 53, p. 1\u201340."},{"key":"10.1016\/j.vaccine.2018.08.053_b0050","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ijpharm.2012.07.031","article-title":"Novel lipid based oral formulation of curcumin: development and optimization by design of experiments approach","volume":"436","author":"Pawar","year":"2012","journal-title":"Int J Pharm"},{"key":"10.1016\/j.vaccine.2018.08.053_b0055","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1128\/JVI.02175-09","article-title":"Gastrointestinal delivery of baculovirus displaying influenza virus hemagglutinin protects mice against heterologous H5N1 infection","volume":"84","author":"Prabakaran","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.08.053_b0060","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S1473-3099(15)00266-2","article-title":"High titre neutralising antibodies to influenza after oral tablet immunisation: a phase 1, randomised, placebo-controlled trial","volume":"15","author":"Liebowitz","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2018.08.053_b0065","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1021\/bc100083d","article-title":"Conjugation to nickel-chelating nanolipoprotein particles increases the potency and efficacy of subunit vaccines to prevent West Nile encephalitis","volume":"21","author":"Fischer","year":"2010","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.vaccine.2018.08.053_b0070","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1016\/j.vaccine.2005.03.050","article-title":"Vaccine and adjuvant activity of recombinant subunit B of E. coli enterotoxin produced in yeast","volume":"23","author":"Fingerut","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.053_b0075","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.vaccine.2010.11.091","article-title":"Non-toxic derivatives of LT as potent adjuvants","volume":"29","author":"da Hora","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.053_b0080","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0264-410X(92)90071-Q","article-title":"Synthetic recombinant vaccine expressing influenza haemagglutinin epitope in Salmonella flagellin leads to partial protection in mice","volume":"10","author":"McEwen","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.053_b0085","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1128\/IAI.74.2.1113-1120.2006","article-title":"Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis","volume":"74","author":"Honko","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.08.053_b0090","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/CVI.00333-08","article-title":"Flagellin-F1-V fusion protein is an effective plague vaccine in mice and two species of nonhuman primates","volume":"16","author":"Mizel","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.08.053_b0095","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.1016\/j.vaccine.2005.07.098","article-title":"Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB\/c mice","volume":"23","author":"Pushko","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.053_b0100","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1128\/JVI.02052-06","article-title":"Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus","volume":"81","author":"Quan","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.08.053_b0105","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.intimp.2017.12.020","article-title":"Intramuscular and intranasal immunization with an H7N9 influenza virus-like particle vaccine protects mice against lethal influenza virus challenge","volume":"58","author":"Ren","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.vaccine.2018.08.053_b0110","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.vetmic.2012.11.035","article-title":"Protective efficacy of baculovirus-derived influenza virus-like particles bearing H5 HA alone or in combination with M1 in chickens","volume":"162","author":"Choi","year":"2013","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2018.08.053_b0115","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1006\/viro.1998.9488","article-title":"Characterization of avian H5N1 influenza viruses from poultry in Hong Kong","volume":"252","author":"Shortridge","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.08.053_b0120","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3109\/08820139.2013.864665","article-title":"A pandemic H1N1 influenza virus-like particle vaccine induces cross-protection in mice","volume":"43","author":"Inn","year":"2014","journal-title":"Immunol Invest"},{"key":"10.1016\/j.vaccine.2018.08.053_b0125","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1128\/JVI.01692-06","article-title":"Incorporation of glycosylphosphatidylinositol-anchored granulocyte- macrophage colony-stimulating factor or CD40 ligand enhances immunogenicity of chimeric simian immunodeficiency virus-like particles","volume":"81","author":"Skountzou","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.08.053_b0130","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1128\/IAI.65.7.2821-2828.1997","article-title":"Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin","volume":"65","author":"Douce","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.08.053_b0135","doi-asserted-by":"crossref","first-page":"10795","DOI":"10.1073\/pnas.91.23.10795","article-title":"Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance","volume":"91","author":"Sun","year":"1994","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2018.08.053_b0140","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.0105-2896.2005.00280.x","article-title":"Oral tolerance","volume":"206","author":"Faria","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2018.08.053_b0145","doi-asserted-by":"crossref","first-page":"11813","DOI":"10.1128\/JVI.01076-08","article-title":"Incorporation of membrane-anchored flagellin into influenza virus-like particles enhances the breadth of immune responses","volume":"82","author":"Wang","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.08.053_b0150","doi-asserted-by":"crossref","first-page":"e13972","DOI":"10.1371\/journal.pone.0013972","article-title":"Intranasal immunization with influenza VLPs incorporating membrane-anchored flagellin induces strong heterosubtypic protection","volume":"5","author":"Wang","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2018.08.053_b0155","doi-asserted-by":"crossref","first-page":"e63384","DOI":"10.1371\/journal.pone.0063384","article-title":"Recombinant rabies viruses expressing GM-CSF or flagellin are effective vaccines for both intramuscular and oral immunizations","volume":"8","author":"Zhou","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2018.08.053_b0160","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1128\/IAI.72.5.2810-2816.2004","article-title":"Flagellin fusion proteins as adjuvants or vaccines induce specific immune responses","volume":"72","author":"Cuadros","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.08.053_b0165","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1586\/14760584.6.3.401","article-title":"Implication of nanoparticles\/microparticles in mucosal vaccine delivery","volume":"6","author":"Vyas","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2018.08.053_b0170","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev.immunol.21.120601.141126","article-title":"Toll-like receptors","volume":"21","author":"Takeda","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2018.08.053_b0175","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/15058","article-title":"Advances in vaccine adjuvants","volume":"17","author":"Singh","year":"1999","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.vaccine.2018.08.053_b0180","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.4049\/jimmunol.169.7.3914","article-title":"Bacterial flagellin is an effective adjuvant for CD4(+) T cells in vivo","volume":"169","author":"McSorley","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.08.053_b0185","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.molmed.2010.05.002","article-title":"Alternative influenza vaccines made by insect cells","volume":"16","author":"Krammer","year":"2010","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.vaccine.2018.08.053_b0190","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12033-010-9268-3","article-title":"Trichoplusia ni cells (High Five(TM)) are highly efficient for the production of influenza A virus-like particles: a comparison of two insect cell lines as production platforms for influenza vaccines","volume":"45","author":"Krammer","year":"2010","journal-title":"Mol Biotechnol"},{"key":"10.1016\/j.vaccine.2018.08.053_b0195","doi-asserted-by":"crossref","unstructured":"Margine I, Martinez-Gil L, Chou YY, Krammer F. Residual baculovirus in insect cell-derived \u5c0fInfluenza virus-like particle preparations enhances immunogenicity. PloS One 2012;7.","DOI":"10.1371\/journal.pone.0051559"},{"key":"10.1016\/j.vaccine.2018.08.053_b0200","doi-asserted-by":"crossref","unstructured":"Hervas-Stubbs S, Rueda P, Lopez L, Leclerc C. Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN (vol 178, pg 2361, 2007). J Immunol 2007;178:6653-.","DOI":"10.4049\/jimmunol.178.10.6653"},{"key":"10.1016\/j.vaccine.2018.08.053_b0205","doi-asserted-by":"crossref","first-page":"7826","DOI":"10.1016\/j.vaccine.2011.07.099","article-title":"Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico","volume":"29","author":"Lopez-Macias","year":"2011","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18311824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18311824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T12:55:43Z","timestamp":1604840143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18311824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":41,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0264410X18311824"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.08.053","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inclusion of membrane-anchored LTB or flagellin protein in H5N1 virus-like particles enhances protective responses following intramuscular and oral immunization of mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.08.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}